Moderna, Inc.
Moderna, Inc. (MRNA) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
mrna · stock forecast · 27 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 27 Wall Street analysts in the past 3 months
Hold
27 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$49.00
Consensus
$40.29
-15.1% upside
Low
$33.00
Median: $38 · Last Close: $47.44
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$40.29
-15.1% upside
High Target
$49
3.3%
Low Target
$33
-30.4%
Current Price
$47.44
as of today
Based on analyst price targets, the MRNA stock price prediction for the next 12 months ranges from $33 to $49. The consensus MRNA price forecast of $40.29 implies -15.1% upside from the current price of $47.44.
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $46.99 | ↓ 0.94% |
1-day model range: $46.12–$47.86. Peak: $47.86 (-0.94%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -30.0% |
| 2028 | — | -43.7% |
| 2029 | — | -50.8% |
| 2030 | — | -54.8% |
| 2031 | — | -57.3% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · MRNA · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-04 | Evercore ISI Group | Maintains | In Line→In Line |
| 2026-05-04 | UBS | Maintains | Neutral→Neutral |
| 2026-05-04 | Goldman Sachs | Maintains | Neutral→Neutral |
| 2026-05-04 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2026-04-02 | Barclays | Maintains | Equal Weight→Equal Weight |
| 2026-02-23 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-02-17 | Evercore ISI Group | Maintains | In Line→In Line |
| 2026-02-17 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2026-02-17 | Goldman Sachs | Maintains | Neutral→Neutral |
| 2025-12-12 | Morgan Stanley | Maintains | Equal Weight→Equal Weight |
Wall Street analysts have recently issued updated ratings on Moderna, Inc. (MRNA) stock. Of the recent 192 rating actions, 12 were upgrades and 21 were downgrades. 27 analysts currently cover MRNA.
Analyst Recommendation Trends
MRNA analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$2.1B
↓ 33.2% YoY
Revenue Next Year
$2.5B
↑ 19.0% YoY
EPS This Year
$-8.59
EPS Next Year
$-4.72
↓ 45.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast MRNA EPS of $-8.59 for the current fiscal year, based on estimates from 17 analysts. The MRNA revenue forecast is $2.1B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The MRNA stock forecast is supported by two independent data sources: analyst consensus ratings from 27 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus MRNA price target is $40.29 (-15.1% upside), with an analyst consensus of Hold.
The MRNA short-term stock prediction for tomorrow is $46.99 (-0.94%). The MRNA stock prediction for 2030 projects a range of $20–$23.
Moderna, Inc. trades on NASDAQ under the ticker MRNA. The MRNA stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 26% of covering analysts.
Frequently asked questions
MRNA forecast · 8 questionsAccording to 27 Wall Street analysts, the average 12-month MRNA price target is $40.29, with a high forecast of $49.00 and a low of $33.00. The median price target is shown in the chart above when available. This implies -15.1% potential upside from the current price of $47.44.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.